Patients told which AI is used in their care, in plain language
Every patient would be able to see which AI tools were used in their diagnosis or treatment plan, what they do, how well they work and how to question them.
Patients are rarely informed when AI has contributed to their diagnosis or plan. The proposal requires a patient-facing model card, drawn from the model registry, attached to the patient's record whenever an AI tool influences care: what the tool did, its validated performance in plain terms, the version, and how to request human review. This supports informed consent, builds trust and creates a feedback channel for errors.
- AI that is built but not validated or deployed · Thousands of cancer AI models are published; a handful are in clinical use, and fewer have shown they help patients.
- Patients lack understanding, navigation and agency · Most patients cannot understand their options, find trials, or push back, so decisions are made for them.
Pages like this
not linked directly; found by shared links- IdeaA liability framework for clinical AI: safe harbour for clinicians, liability for makers
Shares A public registry of every AI model used in cancer care, AI that is built but not validated or deployed.
- IdeaRules for retiring cancer AI when performance drops or the standard of care moves
Shares A public registry of every AI model used in cancer care, AI that is built but not validated or deployed.
- IdeaMandatory post-market performance reporting for cancer AI
Shares A public registry of every AI model used in cancer care, AI that is built but not validated or deployed.
- CompanyTempus AI
Shares Patients lack understanding, navigation and agency, AI that is built but not validated or deployed.